Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
HBM Holdings Limited (2142 HK)
Watchlist
36
Analysis
Health Care
•
Hong Kong
HBM Holdings Limited operates as a biopharmaceutical company. The Company develops novel and highly differentiated antibody therapeutics in immunology and oncology disease areas. HBM Holdings provides its services throughout China.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
JD Health International
•
29 Nov 2020 13:02
ECM Weekly (29 November 2020) - JD Health, Evergrande Svcs, CR Svcs, Pop Mart, Nuix and More
A few big IPOs launched in Hong Kong this week, namely, JD Health, Evergrande Services, and CR Mixc Services. Interestingly, the trio drew strong...
Zhen Zhou, Toh
304 Views
Share
bullish
•
HBM Holdings Limited
•
26 Nov 2020 16:49
HBM Holdings (Harbour Biomed) IPO Initiation: Making Resistance Futile
Harbour is seeking to raise $300 million through a Hong Kong IPO. Harbour’s three antibody platforms are a key source of differentiation. Overall,...
Arun George
Follow
474 Views
Share
bullish
•
HBM Holdings Limited
•
17 Nov 2020 16:38
HBM (和珀医药) Pre-IPO: Thoughts on Valuation
In this note, we will focus on the valuation of HBM9161/batoclimab and HBM9036/tanfanercept and give empirical valuation for HBM4003.
Ke Yan, CFA, FRM
Follow
467 Views
Share
bullish
•
HBM Holdings Limited
•
03 Nov 2020 14:46
HBM (和珀医药) Pre-IPO: Innovative Heavy Chain Platform to Be Tested
HBM Holdings is a China-based biopharmaceutical company. The company plans to raise at least USD 500m to list in Hong Kong.
Ke Yan, CFA, FRM
Follow
317 Views
Share
First
Previous
4
5
6
7
8
Next
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x